Replies to post #322865 on Amarin Corp Plc (AMRN)

[HinduKush]

JB
It looks they are randomizing 1:10 IPE Vascepa to usual care and then later adjusting for age and comorbidities between the groups for moderate-severe URTI (including Cov-19)outcomes comparisons. Interesting will be the issue of how vaccination incidence and its effects will be adjusted for in the analysis.